Patent · US Active

Anti-CD154 antibodies and methods of using them

US10669343B2 · kind B2 · utility

1Cited by
34References
66Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 4, 2016
Grant dateJun 2, 2020
Priority date
Expiry dateJan 2, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to antagonistic antibodies specifically binding CD154, polynucleotides encoding the antibodies or fragments, and methods of making and using the foregoing.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.